146 related articles for article (PubMed ID: 5171384)
1. Recurrent thyrotoxicosis after subtotal thyroidectomy.
Hedley AJ; Ross IP; Beck JS; Donald D; Albert-Recht F; Michie W; Crooks J
Br Med J; 1971 Oct; 4(5782):258-61. PubMed ID: 5171384
[TBL] [Abstract][Full Text] [Related]
2. Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
Werner SC; Feind CR; Aida M
N Engl J Med; 1967 Jan; 276(3):132-8. PubMed ID: 6071187
[No Abstract] [Full Text] [Related]
3. Recurrent thyrotoxicosis after subtotal thyroidectomy.
Hedley AJ; Ross IP; Beck JS; Donald D; Recht FA; Michie W; Crooks J
J Endocrinol; 1970 Dec; 48(4):57-8. PubMed ID: 5536912
[No Abstract] [Full Text] [Related]
4. The immunologic basis of Graves's disease.
Volpé R
N Engl J Med; 1972 Aug; 287(9):463-4. PubMed ID: 5068098
[No Abstract] [Full Text] [Related]
5. Hypothyroidism after thyroidectomy for Graves's disease: a search for an explanation.
Van Welsum M; Feltkamp TE; De Vries MJ; Doctor R; Van Zijl J; Hennemann G
Br Med J; 1974 Dec; 4(5947):755-6. PubMed ID: 4613425
[TBL] [Abstract][Full Text] [Related]
6. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
[TBL] [Abstract][Full Text] [Related]
7. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs.
Mukhtar ED; Smith BR; Pyle GA; Hall R; Vice P
Lancet; 1975 Mar; 1(7909):713-5. PubMed ID: 47482
[TBL] [Abstract][Full Text] [Related]
8. A study of the change in serum TBII before and after subtotal thyroidectomy for hyperthyroidism.
Hoshi T
Fukushima J Med Sci; 1985 Jun; 31(1):1-16. PubMed ID: 2867960
[No Abstract] [Full Text] [Related]
9. Identification of subgroups of euthyroid graves's ophthalmopathy.
Solomon DH; Chopra IJ; Chopra U; Smith FJ
N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
[TBL] [Abstract][Full Text] [Related]
10. Long-acting thyroid stimulator and related factors.
Kendall-Taylor P; Dirmikis SM; Munro DS
Proc R Soc Med; 1975 Apr; 68(4):252-3. PubMed ID: 1242809
[No Abstract] [Full Text] [Related]
11. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
12. The long-term outcomes of thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism.
Lin YS; Lin JD; Hsu CC; Yu MC
J Surg Res; 2017 Dec; 220():112-118. PubMed ID: 29180171
[TBL] [Abstract][Full Text] [Related]
13. [A study of thyroid function in patients with Graves' disease after 5 to 10 years of subtotal thyroidectomy: with special emphasis on TRH tests, T3 suppression tests and antithyroid antibodies in euthyroid patients (author's transl)].
Fukino O; Tamai H; Mori K; Ohsako N; Takeno K; Esaki M; Matsuzuka F; Kuma K; Nagataki S
Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1581-90. PubMed ID: 6799335
[No Abstract] [Full Text] [Related]
14. A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves' disease treated by subtotal thyroidectomy or radioactive iodine.
Teng CS; Yeung RT; Khoo RK; Alagaratnam TT
J Clin Endocrinol Metab; 1980 Jun; 50(6):1005-10. PubMed ID: 6103007
[TBL] [Abstract][Full Text] [Related]
15. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
Hu YM; Liu W; Lu GH
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
[TBL] [Abstract][Full Text] [Related]
16. The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.
Munro DS; Dirmikis SM; Humphries H; Smith T; Broadhead GD
Br J Obstet Gynaecol; 1978 Nov; 85(11):837-43. PubMed ID: 581471
[No Abstract] [Full Text] [Related]
17. LATS-protector activity in thyrotoxicosis measured by thyroidal intracellular colloid droplet formation.
Shishiba Y; Miyachi Y; Takaishi M; Ozawa Y
J Clin Endocrinol Metab; 1978 May; 46(5):841-8. PubMed ID: 262769
[TBL] [Abstract][Full Text] [Related]
18. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
19. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Adams DD; Kennedy TH; Stewart RD
Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
[TBL] [Abstract][Full Text] [Related]
20. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
